Ameritas Advisory Services’s Eledon Pharmaceuticals ELDN Stock Holding History

Ameritas Advisory Services’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,000	Closed	-$2.71K	–	2347
2025 Q2	$2.71K	Buy	+1,000	New	+$3K	﹤0.01%	2420
2023 Q2	–	Sell	-1,000	Closed	-$2.27K	–	1096
2023 Q1	$2.27K	Buy	+1,000	New	+$2.68K	﹤0.01%	2359
2022 Q1	–	Sell	-24,219	Closed	-$107K	–	838
2021 Q4	$107K	Buy	+24,219	New	+$123K	﹤0.01%	795

Other funds holding ELDN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Ameritas Advisory Services's ELDN Position: Q3 2025 in Review

Ameritas Advisory Services sold out of Eledon Pharmaceuticals (ELDN) in Q3 2025, closing a stake of 1,000 shares — an estimated $2.71K sold.

Ameritas Advisory Services first reported a position in ELDN in Q4 2021 and held it in 3 quarters. The position peaked at $107K in Q4 2021. 83 funds tracked by Wall St. Rank hold ELDN as of Q3 2025.

Ameritas Advisory Services reported no remaining Eledon Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Ameritas Advisory Services sold 1,000 Eledon Pharmaceuticals shares in Q3 2025, an estimated $2.71K.
Ameritas Advisory Services first reported a position in Eledon Pharmaceuticals in Q4 2021 and held it in 3 quarters.
Ameritas Advisory Services's Eledon Pharmaceuticals position peaked at $107K in Q4 2021.
83 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2025.

Based on Ameritas Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.